TOCA is pleased to announce that David S Bailie MD has
been selected as a principal investigator of a new stemless total shoulder
replacement device. This is a randomized study being conducted at 12 FDA
approved medical facilities in the US. Dr. Bailie is the only orthopedic
surgeon approved to use this device in the western US (west of Memphis, TN).
This FDA approved study is
being sponsored by Biomet Orthopedics ( a worldwide manufacturer/distributor of
Orthopedic devices, www.Biomet.com).
Dr.
Bailie has been selected by the FDA and the Western Institutional Review Board
to participate and enroll qualified patients. The device has already been
released and is currently being used in several European countries and the UK.
Because the device is uniquely different than any current shoulder replacement
on the market, in the US it requires a specifically designed FDA approved
study, to be conducted by select surgeons, prior to general release to the
remainder of the medical community. Until the study is complete (approximately
5-7 years), it will only be available as part of this study. Dr. Bailie is very
excited to have been asked to participate in this "cutting-edge"
research and be able to offer his patients a unique opportunity to participate.
Participating orthopedic surgeons is by invitation only.
TOCA
602-277-6211
www.tocamd.com
